Single-source·Aug 28, 2026·1 sources analyzed
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs (stat-news-source-index)